So…. Let’s recap for all the people who still don’t
So…. Let’s recap for all the people who still don’t believe our company is being intentionally push down by an evil empire.
1. The FDA writes a hit piece, but refuses to tell us who the author was, even when we go through the proper channels.
2. The FDA attempts to remove our video from YouTube, by using lobbyist from Google to do their dirty work. When we go thru the proper channels to take a look at the emails, they claim they have no record of any emails on the subject.
3. In 2018, Amarex is purchased by a large company and all of a sudden their data collecting becomes sloppy and they make elementary errors and when they are told exactly what needs to be corrected, they decide not to comply.
4. This one is my opinion…. Why the hell does the FDA make us wait 6 months to start our next LH trial when US citizens are living with horrible physical conditions which leronlimab has been shown to improve.
5. Here’s another one…. FDA tells CYDY to stop compassionate use in the US so we can focus on finishing our trials, even though highly recognized doctors are writing papers on the amazing results they are observing when their patients are given leronlimab.
6. Just remembered, the FDA tells us to use 2 doses on our patients instead of 4 like we asked for but let’s make the primary endpoint day 28.
7. FDA tells us that the DSMC checked in on our data and everything looks great… don’t change a thing.
These are 7 instances I can recall while I’m sitting here and I’m starting to get fired up that no one is being held accountable for dicking us around for years while citizens have died and the only therapy they approve is remdesivir, which I guarantee killed more people than it saved. Something is terribly wrong here and I have a feeling the our heavy hitting law firm wants answers to these questions. I hope they get them, and I hope heads roll when people find out how corrupt the FDA has been throughout this pandemic!!!!!!
15
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...
Continue Reading
Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...
Continue Reading
What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...
Continue Reading
The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...
Continue Reading
Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...
Continue Reading
One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...
Continue Reading
Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....
Continue Reading
IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...
Continue Reading
Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...
Continue Reading
Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...
Continue Reading
Top 5 Most Recently Viewed Articles
Coca-Cola's Current Market Challenges Coca-Cola Co (NYSE: KO) is widely recognized for its iconic beverages, yet its current stock performance has been less than encouraging. Recently, Coca-Cola shares have entered a technical stage known as a Death Cross, indicating a potential downturn. This significant development occurs when the 50-day moving average dips below the...
Continue Reading
Canadian Life Companies Split Corp. Completes Successful Offering Toronto-based Canadian Life Companies Split Corp. has successfully completed the overnight marketing of its Preferred Shares (TSX: LFE.PR.B) and Class A Shares (TSX: LFE). This impressive offering is anticipated to raise approximately $40 million in total gross proceeds. The initiative was spearheaded by...
Continue Reading
Investigation of LINKBANCORP's Transaction The Ademi Firm is currently investigating LINKBANCORP (NASDAQ: LNKB) concerning potential breaches of fiduciary duty in its recently announced transaction with Burke & Herbert. This scrutiny arises from the conditions surrounding the deal and how they may affect the shareholders’ interests. Transaction Overview Under the terms...
Continue Reading
Overview of AppFolio's Recent Performance Recently, AppFolio Inc. (NASDAQ: APPF) has seen updates from Piper Sandler regarding its stock outlook. After reviewing AppFolio's performance, the firm has modified its price target from $300 down to $265 while maintaining an Overweight rating. This adjustment follows remarkable third-quarter results that showcased a 24% increase...
Continue Reading
Partnership Enhancing Home-Based Healthcare Delivery WellBe Senior Medical has recently formed a strategic partnership with Security Health Plan to enhance the delivery of home-based medical care across multiple regions. This collaboration aims to improve access to essential healthcare services for seniors, particularly those grappling with complex health conditions....
Continue Reading